- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07946809
Periodontal Health and Treatment Outcomes in Students From Three Countries
Investigation of the Prevalence, Severity, and Treatment Response of Periodontal Diseases Among Student Groups From Different Countries
This study aims to investigate the prevalence and severity of periodontal diseases among university students from three different national backgrounds (Iranian, Sudanese, and Turkish) and to evaluate their response to periodontal treatment.
A total of 348 students will be included in the study, comprising 116 Iranian, 116 Sudanese, and 116 Turkish students. Periodontal health assessments will be performed, and all participants will receive periodontal treatment according to the study protocol.
The study will compare periodontal disease prevalence and severity among the three groups and evaluate changes in periodontal health following treatment.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This study investigates the prevalence and severity of periodontal diseases among university students from three different national backgrounds and evaluates their response to periodontal treatment.
A total of 348 university students will be included in the study, consisting of 116 students of Iranian origin, 116 students of Sudanese origin, and 116 students of Turkish origin.
At baseline, all participants will undergo a comprehensive periodontal examination to assess their periodontal health status. Clinical periodontal parameters will be recorded using standardized periodontal assessment methods.
All participants will receive periodontal treatment according to the study protocol. The treatment includes professional scaling and oral hygiene instruction. Root planing will be performed when clinically indicated, depending on the periodontal condition of each participant.
Three weeks after treatment, participants will undergo a follow-up periodontal examination. Clinical periodontal parameters will be reassessed to evaluate changes in periodontal health and treatment response.
The findings will be compared among the three student groups to investigate differences in periodontal disease prevalence, severity, and response to treatment.
The study aims to provide information about periodontal health differences among students from different national backgrounds and their response to periodontal treatment.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Esra İlkerli Şençağlı, Dt.
- Número de teléfono: +905338408701
- Correo electrónico: esra.ilkerli@kstu.edu.tr
Ubicaciones de estudio
-
-
-
Mórfou, Chipre
- Reclutamiento
- Cyprus Health and Social Sciences University
-
Contacto:
- Esra İlkerli Şençağlı
- Número de teléfono: +905338408701
- Correo electrónico: esra.ilkerli@kstu.edu.tr
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Being 18 years of age or older.
- Having been born and raised in a country different from the country of current study.
- Currently being enrolled as a student at Cyprus Health and Social Sciences University.
- Having received no periodontal treatment within the previous six months.
- Having at least 20 natural teeth.
- Voluntarily agreeing to participate in the study and providing written informed consent.
Exclusion Criteria:
- Completely edentulous individuals.
- Individuals who have used systemic antibiotics or anti-inflammatory medications within the previous six months.
- Individuals with a history of periodontal surgery.
- Pregnant or breastfeeding individuals.
- Individuals with immunosuppression due to systemic diseases or medical conditions (e.g., chemotherapy or HIV).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Periodontal Treatment Group
All 348 participants will receive periodontal treatment according to their individual clinical needs. Treatment will include scaling and root planing when clinically indicated. Participants will be evaluated at baseline and reassessed three weeks after treatment to assess periodontal treatment outcomes. |
Participants will receive non-surgical periodontal treatment according to their individual clinical needs. The treatment will include scaling and root planing where clinically indicated. The procedure will be performed based on baseline periodontal examination findings. All participants will be reassessed three weeks after treatment to evaluate changes in periodontal clinical parameters, including plaque index, gingival index, probing pocket depth, clinical attachment level, and tooth mobility. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Probing Pocket Depth (PPD)
Periodo de tiempo: Baseline and 3 weeks after periodontal treatment
|
Change in mean probing pocket depth (PPD) from baseline to the three-week follow-up after periodontal treatment. Measurements will be compared among Iranian, Sudanese, and Turkish student groups. |
Baseline and 3 weeks after periodontal treatment
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Plaque Index (PI) Assessed Using the Silness and Löe Plaque Index
Periodo de tiempo: Baseline and 3 weeks
|
Dental plaque will be assessed clinically using the Silness and Löe Plaque Index (1964). Plaque accumulation will be scored on a scale ranging from 0 to 3: 0: No plaque.
The minimum score is 0 and the maximum score is 3. Higher scores indicate greater plaque accumulation and a worse oral hygiene outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment. |
Baseline and 3 weeks
|
|
Change in Gingival Index (GI) Assessed Using the Löe and Silness Gingival Index
Periodo de tiempo: Baseline and 3 weeks
|
Gingival inflammation will be assessed clinically using the Löe and Silness Gingival Index (1963). Gingival tissues will be scored on a scale ranging from 0 to 3: 0: Normal gingiva, no inflammation.
The minimum score is 0 and the maximum score is 3. Higher scores indicate more severe gingival inflammation and a worse periodontal outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment. |
Baseline and 3 weeks
|
|
Change in Clinical Attachment Level (CAL)
Periodo de tiempo: Baseline and 3 weeks
|
Baseline and 3 weeks
|
|
|
Change in Tooth Mobility Assessed Using the Miller Mobility Index
Periodo de tiempo: Baseline and 3 weeks
|
Tooth mobility will be assessed clinically using the Miller Mobility Index. Each examined tooth will be evaluated for horizontal and vertical mobility using two rigid instrument handles. Mobility will be classified as follows: Grade 0: Physiologic tooth mobility. Grade 1: Slight horizontal mobility of less than 1 mm. Grade 2: Horizontal mobility of more than 1 mm without vertical mobility. Grade 3: Severe horizontal mobility accompanied by vertical mobility. Higher grades indicate greater tooth mobility and a worse periodontal outcome. Tooth mobility will be assessed at baseline and 3 weeks after periodontal treatment. |
Baseline and 3 weeks
|
|
Change in Bleeding on Probing (BOP) Percentage
Periodo de tiempo: Baseline and 3 weeks
|
Bleeding on probing (BOP) will be assessed as a clinical indicator of gingival inflammation using a periodontal probe. The periodontal probe will be gently inserted into the gingival sulcus to evaluate the presence or absence of bleeding following probing. Each periodontal site will be recorded using a dichotomous scoring system: Score 0: Absence of bleeding on probing. Score 1: Presence of bleeding on probing. The BOP percentage will be calculated by dividing the total number of bleeding-positive sites by the total number of examined periodontal sites and multiplying by 100. BOP (%) = (Number of bleeding-positive sites / Total number of examined sites) × 100. The minimum value is 0% and the maximum value is 100%. Higher percentages indicate a greater proportion of bleeding sites and more pronounced gingival inflammation. |
Baseline and 3 weeks
|
|
Prevalence and Severity of Periodontal Disease
Periodo de tiempo: Baseline
|
Baseline
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Silla de estudio: Halil İbrahim Taşer, Prof.Dr., Cyprus Health and Social Sciences University
- Investigador principal: Esra İlkerli Şençağlı, Dt., Cyprus Health and Social Sciences University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades de la Boca
- Enfermedades Estomatognáticas
- Infecciones
- Enfermedades gingivales
- Periodontitis
- Enfermedades periodontales
- Gingivitis
- Sistema digestivo y fenómenos fisiológicos orales
- Odontología
- Fenómenos fisiológicos dentales
- Escala dental
- Profilaxis dental
- Periodoncia
- Legrado subgingival
- Odontología preventiva
- Planificación de raíz
- Exfoliación Dental
Otros números de identificación del estudio
- ESRA-PERIO-001
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .